These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6184106)
1. Bladder outflow obstruction treated with phenoxybenzamine. Abrams PH; Shah PJ; Stone R; Choa RG Br J Urol; 1982 Oct; 54(5):527-30. PubMed ID: 6184106 [TBL] [Abstract][Full Text] [Related]
2. Bladder outflow obstruction treated with phenoxybenzamine. Abrams PH; Shah PJ; Stone R; Choa RG Prog Clin Biol Res; 1981; 78():269-75. PubMed ID: 6174998 [TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Caine M; Perlberg S; Meretyk S Br J Urol; 1978 Dec; 50(7):551-4. PubMed ID: 88984 [TBL] [Abstract][Full Text] [Related]
5. A double-blind controlled trial of a new alpha-1 blocking drug in the treatment of bladder outflow obstruction. Ramsay JW; Scott GI; Whitfield HN Br J Urol; 1985 Dec; 57(6):657-9. PubMed ID: 2417649 [TBL] [Abstract][Full Text] [Related]
6. Indoramin in the treatment of prostatic bladder outflow obstruction. Stott MA; Abrams P Br J Urol; 1991 May; 67(5):499-501. PubMed ID: 1710162 [TBL] [Abstract][Full Text] [Related]
11. A modern rationale for the use of phenoxybenzamine in urinary tract disorders and other conditions. Te AE Clin Ther; 2002 Jun; 24(6):851-61; discussion 837. PubMed ID: 12117078 [TBL] [Abstract][Full Text] [Related]
12. Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases. Caine M; Perlberg S; Shapiro A Urology; 1981 Jun; 17(6):542-6. PubMed ID: 6166111 [TBL] [Abstract][Full Text] [Related]
13. Treatment of benign prostatic hyperplasia with phytosterols. Carbin BE; Larsson B; Lindahl O Br J Urol; 1990 Dec; 66(6):639-41. PubMed ID: 1702340 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of tamsulosin hydrochloride on bladder outlet obstruction associated with benign prostatic hyperplasia: effect on urethral pressure profile and cystometrogram]. Murayama K; Katsumi T; Tajika E; Kawaguchi K; Ueki O Hinyokika Kiyo; 1997 Nov; 43(11):799-803. PubMed ID: 9436025 [TBL] [Abstract][Full Text] [Related]
15. Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation. Ronchi F; Margonato A; Ceccardi R; Rigatti P; Rossini BM Urol Res; 1982; 10(3):131-4. PubMed ID: 6182672 [TBL] [Abstract][Full Text] [Related]
16. Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia. Chen KK; Chang LS; Chen MT; Huang JK; Yin JH; Lin SN; Lin AD Zhonghua Yi Xue Za Zhi (Taipei); 1988 Feb; 41(2):127-30. PubMed ID: 2458811 [No Abstract] [Full Text] [Related]
17. Urodynamic effects of finasteride in the treatment of bladder outlet obstruction due to benign prostatic hyperplasia. Tammela TL; Kontturi MJ J Urol; 1993 Feb; 149(2):342-4. PubMed ID: 7678871 [TBL] [Abstract][Full Text] [Related]
18. Pressure-to-cross-sectional area relationships in the proximal urethra of men with bladder outlet obstruction. Graversen PH; Bagi P; Tofft HP; Colstrup H; Kristensen JK J Urol; 1996 Jan; 155(1):267-70. PubMed ID: 7490852 [TBL] [Abstract][Full Text] [Related]
19. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia. Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065 [TBL] [Abstract][Full Text] [Related]